Table 3. β-Carboline derivatives from Pfizer.
| ||||
---|---|---|---|---|
Compd | R | R1 | X | IC50a (nM) |
8 | 6-OMe | 1-COOH | NH | 2500 |
9 | 6-OH | 1-COOH | NH | 4500 |
10 | 6-COOMe | 1-COOH | NH | 6600 |
11 | 6-OMe | 1-COOH | NMe | 1000 |
12 | 6-OMe | 1-COOH | NEt | 5800 |
13 | 6-OMe | 1-COOH, 4-Me | NH | 2200 |
14 | 6-OMe | 1-COOH, 4-Et | NH | 2200 |
15 | 6-OMe | 1-COOH, 3-CH2OH | NH | 3000 |
16 | 6-OMe | 1-COOH, 3-CH2NH | NH | 5900 |
17 | H | CH2 | 290 | |
18 | H | CH2CH2 | 5100 | |
19 | n-Pr | CH2 | 10100 |
Expressed as the inhibition of MK2 ability to phosphorylate the KKKALSRQLSVAA peptide.